What are the major opportunities in the Duchenne Muscular Dystrophy (DMD) Therapeutics market? What are the strategies for the Duchenne Muscular Dystrophy (DMD) Therapeutics market?

For detailed insights on the major opportunities and strategies in the Duchenne Muscular Dystrophy (DMD) Therapeutics market, Read More

How does the Duchenne Muscular Dystrophy (DMD) Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Duchenne Muscular Dystrophy (DMD) Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Duchenne Muscular Dystrophy (DMD) Therapeutics market growth? SWOT analysis of the Duchenne Muscular Dystrophy (DMD) Therapeutics market.

For detailed insights on the key dynamics influencing the Duchenne Muscular Dystrophy (DMD) Therapeutics market growth and SWOT analysis of the Duchenne Muscular Dystrophy (DMD) Therapeutics industry, Read More

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2026

Name: Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Small Molecules, Biologics), By Distribution Channel (Offline, Online), By Application (Hospitals, Clinics, Home Care) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

• Duchenne Muscular Dystrophy (DMD) Therapeutics market size has reached to $16.38 billion in 2025

• Expected to grow to $62.13 billion in 2030 at a compound annual growth rate (CAGR) of 30.5%

• Growth Driver: Rise In Clinical Trials Fueling The Growth Of The Market Due To Increasing Demand For Innovative Treatment Evaluation

• Market Trend: Bit Bio Leads Technological Advancements In Duchenne Muscular Dystrophy (DMD) Therapeutics

• North America was the largest region in 2025.

What Is Covered Under Duchenne Muscular Dystrophy (DMD) Therapeutics Market?

Duchenne muscular dystrophy (DMD) therapeutics refers to the various medical treatments and interventions aimed at managing and alleviating the symptoms of duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle weakness and degeneration. These therapeutic approaches are designed to slow disease progression, improve muscle function and enhance the overall quality of life for individuals with duchenne muscular dystrophy.

The main types of duchenne muscular dystrophy (DMD) therapeutics are small molecules and biologics. Small molecules are low-molecular-weight compounds that can interact with specific proteins or targets in the body and they can be designed to target specific aspects of DMD, such as reducing inflammation, promoting muscle regeneration, or addressing specific genetic mutations. Therapeutics are distributed through offline and online channels for applications in hospitals, clinics and home care.

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size and Share 2026?

The duchenne muscular dystrophy (dmd) therapeutics market size has grown exponentially in recent years. It will grow from $16.38 billion in 2025 to $21.43 billion in 2026 at a compound annual growth rate (CAGR) of 30.8%. The growth in the historic period can be attributed to rising prevalence of duchenne muscular dystrophy, increased awareness among healthcare providers, early-stage clinical trials initiation, growing adoption of physiotherapy and supportive care, government incentives for rare disease treatments.

What Is The Duchenne Muscular Dystrophy (DMD) Therapeutics Market Growth Forecast?

The duchenne muscular dystrophy (dmd) therapeutics market size is expected to see exponential growth in the next few years. It will grow to $62.13 billion in 2030 at a compound annual growth rate (CAGR) of 30.5%. The growth in the forecast period can be attributed to advances in gene therapy, growing investment in precision medicine, technological integration in patient monitoring, expansion of biologics manufacturing, increased collaboration between pharma and biotech companies. Major trends in the forecast period include personalized therapeutic development, gene editing and gene therapy advancements, novel drug delivery systems, orphan drug market expansion, patient-centric care models.

Book your 30 minutes free consultation with our research experts

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segmentation

1) By Type: Small Molecules, Biologics

2) By Distribution Channel: Offline, Online

3) By Application: Hospitals, Clinics, Home Care

Subsegments:

1) By Small Molecules: Exon Skipping Therapies, Antisense Oligonucleotides, Read-Through Compounds

2) By Biologics: Gene Therapies, Cell Therapies, Protein Replacement Therapies

What Is The Driver Of The Duchenne Muscular Dystrophy (DMD) Therapeutics Market?

The rising number of clinical trials is expected to propel the growth of the Duchenne muscular dystrophy (DMD) therapeutics market going forward. Clinical trials are research studies conducted on human participants to evaluate the safety, efficacy and potential benefits of new medical treatments, interventions, or drugs. Clinical trials are increasing due to the growing demand for innovative therapies that address unmet medical needs. Duchenne muscular dystrophy (DMD) therapeutics are tested in clinical trials to evaluate their ability to slow disease progression and improve muscle function in patients. For instance, in April 2025, according to the report published by the NLM (National Library of Medicine), US-based government agency, reported that 27,751 interventional clinical trials were initiated in 2023. Therefore, rising number of clinical trials will drive the growth of the Duchenne muscular dystrophy (DMD) therapeutics industry.

Key Players In The Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market

Major companies operating in the duchenne muscular dystrophy (dmd) therapeutics market are BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Exonics Therapeutics Inc., Wave Life Sciences Ltd., MeiraGTx Holdings plc, Editas Medicine Inc., Solid Biosciences Inc., Santhera Pharmaceuticals Holding, Avidity Biosciences LLC, ReveraGen BioPharma Inc., Capricor Therapeutics Inc., Dynacure S.A., Summit Therapeutics plc, CRISPR Therapeutics AG, Akouos Inc., Audentes Therapeutics Inc., Stoke Therapeutics Inc., Astellas Pharma Inc., Translate Bio Inc., Ultragenyx Pharmaceutical Inc.

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Trends and Insights

Major companies operating in the duchenne muscular dystrophy (DMD) therapeutics market are adopting new technologies to enhance the efficacy and accessibility of treatments for DMD patients and sustain their position in the market. For instance, in July 2023, Bit Bio Ltd., a UK-based synthetic biology company, launched disease model products to advance Duchenne muscular dystrophy (DMD) treatments. The disease models, known as ioSkeletal Myocytes DMD Exon 44 Deletion and ioSkeletal Myocytes DMD Exon 52 Deletion, are human skeletal myocytes carrying genetically engineered deletions in the gene responsible for dystrophin protein production. Bit. Bio's models, reprogrammed from induced pluripotent stem cells (iPSCs), provide a consistent and scalable source of human cells for research, addressing challenges associated with variability and the sourcing of primary cells. The models support the development of treatments for DMD, offering insights into disease mechanisms and potential therapies. This advancement could accelerate the work of researchers seeking effective treatments for DMD.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Duchenne Muscular Dystrophy (DMD) Therapeutics Market?

In November 2024, Novartis AG, a Switzerland based pharmaceuticals company, acquired Kate Therapeutics Inc. for $1.1 billion. With this acquisition, Novartis aimed to expand its neuromuscular disease franchise by integrating Kate’s preclinical AAV based gene therapy programs targeting Duchenne muscular dystrophy (DMD) and other muscle disorders. Kate Therapeutics is a US-based biotechnology company that specializes in next-generation gene therapy candidate for DMD using novel capsid and gene regulation technologies.

Regional Insights

North America was the largest region in the DMD therapeutics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Duchenne Muscular Dystrophy (DMD) Therapeutics Market?

The duchenne muscular dystrophy (DMD) therapeutics market includes revenues earned by entities by providing services including gene therapies, genetic testing and counseling, telehealth and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The duchenne muscular dystrophy (DMD) therapeutics market also include sales of casimersen, eteplirsen and golodirsen. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2026?

The duchenne muscular dystrophy (dmd) therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the duchenne muscular dystrophy (dmd) therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$21.43 billion
Revenue Forecast In 2035	$62.13 billion
Growth Rate	CAGR of 30.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Distribution Channel, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Exonics Therapeutics Inc., Wave Life Sciences Ltd., MeiraGTx Holdings plc, Editas Medicine Inc., Solid Biosciences Inc., Santhera Pharmaceuticals Holding, Avidity Biosciences
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Personalized Therapeutic Development

4.2.2 Gene Editing And Gene Therapy Advancements

4.2.3 Novel Drug Delivery Systems

4.2.4 Orphan Drug Market Expansion

4.2.5 Patient-Centric Care Models

5. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Home Care Providers

5.4 Specialty Treatment Centers

5.5 Research Institutes

6. Duchenne Muscular Dystrophy (DMD) Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Duchenne Muscular Dystrophy (DMD) Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segmentation

9.1. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Molecules, Biologics

9.2. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Offline, Online

9.3. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Home Care

9.4. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Exon Skipping Therapies, Antisense Oligonucleotides, Read-Through Compounds

9.5. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Therapies, Cell Therapies, Protein Replacement Therapies

10. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Regional And Country Analysis

10.1. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Duchenne Muscular Dystrophy (DMD) Therapeutics Market

11.1. Asia-Pacific Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Duchenne Muscular Dystrophy (DMD) Therapeutics Market

12.1. China Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Duchenne Muscular Dystrophy (DMD) Therapeutics Market

13.1. India Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market

14.1. Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

14.2. Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Duchenne Muscular Dystrophy (DMD) Therapeutics Market

15.1. Australia Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Duchenne Muscular Dystrophy (DMD) Therapeutics Market

16.1. Indonesia Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market

17.1. South Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

17.2. South Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Duchenne Muscular Dystrophy (DMD) Therapeutics Market

18.1. Taiwan Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

18.2. Taiwan Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market

19.1. South East Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

19.2. South East Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market

20.1. Western Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

20.2. Western Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Duchenne Muscular Dystrophy (DMD) Therapeutics Market

21.1. UK Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Duchenne Muscular Dystrophy (DMD) Therapeutics Market

22.1. Germany Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Duchenne Muscular Dystrophy (DMD) Therapeutics Market

23.1. France Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Duchenne Muscular Dystrophy (DMD) Therapeutics Market

24.1. Italy Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Duchenne Muscular Dystrophy (DMD) Therapeutics Market

25.1. Spain Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market

26.1. Eastern Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

26.2. Eastern Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Duchenne Muscular Dystrophy (DMD) Therapeutics Market

27.1. Russia Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Duchenne Muscular Dystrophy (DMD) Therapeutics Market

28.1. North America Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

28.2. North America Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Duchenne Muscular Dystrophy (DMD) Therapeutics Market

29.1. USA Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

29.2. USA Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market

30.1. Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

30.2. Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Duchenne Muscular Dystrophy (DMD) Therapeutics Market

31.1. South America Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

31.2. South America Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Duchenne Muscular Dystrophy (DMD) Therapeutics Market

32.1. Brazil Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Duchenne Muscular Dystrophy (DMD) Therapeutics Market

33.1. Middle East Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

33.2. Middle East Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market

34.1. Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview

34.2. Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Regulatory and Investment Landscape

36. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Competitive Landscape And Company Profiles

36.1. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Duchenne Muscular Dystrophy (DMD) Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Company Profiles

36.3.1. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. PTC Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Exonics Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Wave Life Sciences Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Other Major And Innovative Companies

MeiraGTx Holdings plc, Editas Medicine Inc., Solid Biosciences Inc., Santhera Pharmaceuticals Holding, Avidity Biosciences LLC, ReveraGen BioPharma Inc., Capricor Therapeutics Inc., Dynacure S.A., Summit Therapeutics plc, CRISPR Therapeutics AG, Akouos Inc., Audentes Therapeutics Inc., Stoke Therapeutics Inc., Astellas Pharma Inc., Translate Bio Inc.

38. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Duchenne Muscular Dystrophy (DMD) Therapeutics Market

40. Duchenne Muscular Dystrophy (DMD) Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Duchenne Muscular Dystrophy (DMD) Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Supply Chain Analysis

Table 4: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Raw Material Providers

Table 5: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Resource Providers

Table 6: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Trends

Table 10: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major End Users

Table 11: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market - Company Scoring Matrix

Table 96: BioMarin Pharmaceutical Inc. Financial Performance

Table 97: Sarepta Therapeutics Inc. Financial Performance

Table 98: PTC Therapeutics Inc. Financial Performance

Table 99: Exonics Therapeutics Inc. Financial Performance

Table 100: Wave Life Sciences Ltd. Financial Performance

Table 101: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Competitive Dashboard

Table 103: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 105: Global, Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 106: Global, Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Supply Chain Analysis

Figure 4: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Raw Material Providers

Figure 5: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Resource Providers

Figure 6: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major Trends

Figure 10: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Major End Users

Figure 11: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market - Company Scoring Matrix

Figure 96: BioMarin Pharmaceutical Inc. Financial Performance

Figure 97: Sarepta Therapeutics Inc. Financial Performance

Figure 98: PTC Therapeutics Inc. Financial Performance

Figure 99: Exonics Therapeutics Inc. Financial Performance

Figure 100: Wave Life Sciences Ltd. Financial Performance

Figure 101: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Competitive Dashboard

Figure 103: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 105: Global, Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 106: Global, Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Musculoskeletal Disorders Drugs Global Market Report 2022 – By Type (Drugs For Rheumatoid Arthritis, Muscle Relaxants, Other Musculoskeletal Disorders Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmaci...

Muscle Pain Treatment Market Report 2026 - Global Outlook – By Pharmacological Treatment (Analgesics, Muscle Relaxants, Topical Analgesics, Other Pharmacological Treatments), By Non-Pharmacological Treatment (Physical Th...

Lupus Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus, Drug-Induced Lupus Erythematosus, Neonatal Lupus), By Treatment Type (Non-Stero...

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2026 - Global Outlook – By Type (Small Molecules, Biologics), By Distribution Channel (Offline, Online), By Application (Hospitals, Clinics, Home Care) - Marke...

Duchenne Muscular Dystrophy Market Report 2026 - Global Outlook – By Therapy (Mutation Suppression, Exon Skipping Approach), By Therapeutic Class (Molecular Based Therapies, Steroid Therapy), By Route Of Administration (...

Vitamin D Therapy Market Report 2026 - Global Outlook – By Administration (Oral, Parenteral), By Purchasing (OTC Drugs, Prescription Drugs), By Age Group (Children, Adults, Senior Adults), By Application (Osteoporosis, R...

Muscle Tension Dysphonia Treatment Market Report 2026 - Global Outlook – By Treatment Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Voice Therapy, Behavioral Counseling), By Age Group (Pediatrics, Adul...

Frequently Asked Questions

How big is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market?

The Duchenne Muscular Dystrophy (DMD) Therapeutics market was valued at $16.38 billion in 2025, increased to $21.43 billion in 2026, and is projected to reach $62.13 billion by 2030.

What is the Duchenne Muscular Dystrophy (DMD) Therapeutics market growth?

The global Duchenne Muscular Dystrophy (DMD) Therapeutics market is expected to grow at a CAGR of 30.5% from 2026 to 2035 to reach $62.13 billion by 2035.

Who are the key players in Duchenne Muscular Dystrophy (DMD) Therapeutics market?

Some Key Players in the Duchenne Muscular Dystrophy (DMD) Therapeutics market Include, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Exonics Therapeutics Inc., Wave Life Sciences Ltd., MeiraGTx Holdings plc, Editas Medicine Inc., Solid Biosciences Inc., Santhera Pharmaceuticals Holding, Avidity Biosciences LLC, ReveraGen BioPharma Inc., Capricor Therapeutics Inc., Dynacure S.A., Summit Therapeutics plc, CRISPR Therapeutics AG, Akouos Inc., Audentes Therapeutics Inc., Stoke Therapeutics Inc., Astellas Pharma Inc., Translate Bio Inc., Ultragenyx Pharmaceutical Inc. .

What is the anticipated growth trend for the Duchenne Muscular Dystrophy (DMD) Therapeutics market?

Major trend in this market includes: Bit Bio Leads Technological Advancements In Duchenne Muscular Dystrophy (DMD) Therapeutics. For further insights on this market. request a sample here

Which region has the most growth potential in the Duchenne Muscular Dystrophy (DMD) Therapeutics market?

North America was the largest region in the DMD therapeutics market in 2025. The regions covered in the duchenne muscular dystrophy (dmd) therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.